The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 328:1044-1045 April 8, 1993 Number 14
NextNext

Bronchodilator Therapy with or without Inhaled Corticosteroid Therapy for Obstructive Airways Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: I wish to comment on the dose of beclomethasone used by Kerstjens et al. (Nov. 12 issue)1 in their study of bronchodilator therapy with and without inhaled corticosteroids for chronic obstructive pulmonary disease (COPD). Readers should be aware that preparations of beclomethasone that are currently available in this country yield 42 µg per puff. The dose used by Kerstjens et al. was 800 µg per day. Thus, a patient would require approximately 20 puffs a day to reach this dose. A 200-puff canister retails for approximately $33. A patient using 20 puffs a day would need three . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.